RIME

#4960
Algorhythm Holdings, Inc. - Common Stock
0.2 6 USD
-0.07%
Market Price
Settore: Tecnologia
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
0.26
0.26
Intervallo Annuale
0.22
4.58
Variazione giornaliera
-7.14%
Variazione Mensile
-39.53%
Variazione di 6 mesi
-84.05%
Variazione Annuale
-87.85%
Chiusura Precedente
0.2 8
Open
0.2 6
Minimo
0.2 6
Massimo
0.2 6
Volume
4
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
Algorhythm Holdings, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Algorhythm Holdings, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Algorhythm Holdings, Inc. quarterly report, Q1 FY2026
10-Q

Algorhythm Holdings, Inc. current report, Q2 FY2025

Full document

Algorhythm Holdings, Inc. (RIME) - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Algorhythm Holdings, Inc. on May 2, 2025. The report addresses Item 8.01 (Other Events) concerning the Company's compliance with Nasdaq listing requirements regarding minimum stockholders' equity.

Key Financial Metrics

  • Stockholders' Equity (Q3 2024): Approximately $2,700,000.
  • Stockholders' Deficit (FY 2024): Approximately $(10,500,000).
  • Warrant Liability (FY 2024): $16,600,000 recorded in connection with Series A and B warrants issued in a December 6, 2024 public offering.
  • Projected Stockholders' Equity (Q1 2025): Expected to exceed $2,500,000.
  • Revenue, Profit, Cash Flow, Debt, Liquidity: The filing text does not provide clear values for these specific metrics.

Material Changes

The Company experienced a significant shift from a stockholders' deficit of $(10,500,000) at the end of fiscal year 2024 to an expected positive equity position in excess of $2,500,000 for the quarter ended March 31, 2025. This change was driven by two primary events during the first fiscal quarter of 2025:

  • All contingencies on Series A warrants were satisfied.
  • All Series B warrants were exercised in full.
  • Consequently, the $16,600,000 warrant liability was reclassified to stockholders' equity.

Outlook and Management Commentary

Management states that the reclassification of the warrant liability will bring the Company into compliance with Nasdaq Listing Rule 5550(b)(1), which mandates a minimum stockholders' equity for continued listing on The Nasdaq Capital Market. The filing does not provide specific forward-looking guidance on revenue, earnings, or operational risks beyond this compliance update.

Investor Verification Checklist

  • Verify the final audited stockholders' equity figure in the upcoming Form 10-Q for the quarter ended March 31, 2025.
  • Confirm the Company's continued compliance status with Nasdaq Listing Rule 5550(b)(1) in subsequent filings.
  • Review the details of the December 6, 2024 public offering to understand the terms of the Series A and B warrants.
  • Assess the impact of the warrant exercises on the Company's capital structure and share count.